Skip to main content

Currently Skimming:

Appendix C: Agenda
Pages 95-102

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 95...
... Research and Identification of Key Principles and Considerations for Risk/Benefit Assessment (10 minutes) Harvey Fineberg Summary of Recent European Meetings on GoF Research (5 minutes)
From page 96...
...  clarify or expand on key issues that emerge from the To presentations 9:15 Session 2: Overview Moderator: Harvey Fineberg Purpose: To provide a brief introduction to the current scientific and technical approaches to virology research and the study of pandemic avian influenza, Severe Acute Respiratory Syndrome (SARS) , and Middle East Respiratory Syndrome (MERS)
From page 97...
... Yoshihiro Kawaoka, University of Wisconsin-Madison What are the key issues on risks that need to be addressed in the assessments that the NIH will undertake? David Relman, Stanford University Respondent: Robert Webster, member of Symposium Planning Committee (15 minutes)
From page 98...
... 1:00 Lunch (boxed lunches will be provided) 2:00 Session 5: Potential Benefits of GoF Research II: Treatment and Response Moderator: Baruch Fischhoff, member of Symposium Planning Committee Focus: Potential for GoF research to accelerate vaccine and antiviral development and potential impact of GoF regulations on vaccine and antiviral development.
From page 99...
... Gregory Koblentz, George Mason University Carol Linden, Biomedical Advanced Research and Development Authority Gigi Kwik Gronvall, University of Pittsburgh Medical Center (UPMC) Center for Health Security Q&A Discussion (30 minutes)
From page 100...
... Ralph Baric, member of the Symposium Planning Committee Robert Lamb, Northwestern University - Reversibility/mitigation? - Special considerations about alternative research methods with less risk?
From page 101...
... •  hat approaches may be available to diminish risks and W achieve benefits simultaneously? •  hat are the key principles and issues that the NIH's risk W and benefit assessments need to include?


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.